Logo
Call us: 91-11-42141242
Email: info@marketsmonitor.com
HOME COMPANY SECTORS CONTACTS
  • TO ACHIEVE HIGH PERFORMANCE

China Pharmaceutical Guidebook...

May, 2013 | 118 Pages | $750.00
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today
 

China Pharmaceutical Guidebook...

Apr, 2013 | 116 Pages | $750.00
China possesses a fourth population in the world and has one of the largest drug
 

China Pharmaceutical Guidebook...

Apr, 2013 | 121 Pages | $750.00
A Guidebook of Registration Application for Imported Chemical Drugs provide a detailed introduction of SFDA’s requirements for materials and clinical
 

Industry: Pharma

Healthcare Industry » Pharma

China Pharmaceutical Guidebook Series (3) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products

Apr, 2013  | Pages: 169
A Guidebook of Registration Application for Imported Biological Products provides a comprehensive and thorough knowledge of application for imported biological product registration with the Chinese drug regulatory authorities to guide overseas...

Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes

Nov, 2012  | Pages: 87
Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion Diagnostics to Optimize Therapeutic Outcomes Summary GBI Research’s new report, “Biomarkers in Drug Discovery - Integration in Early Stage Promotes Use of Companion

Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities

Nov, 2012  | Pages: 75
Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities Summary GBI Research, the leading business intelligence provider, has released its latest research “Cell Culture

Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen

Nov, 2012  | Pages: 85
Contraceptives Market to 2018 - Safety Concerns Plague Drospirenone-containing Birth Control Pills and Long-term Use of Estrogen Summary GBI Research, a leading business intelligence provider, has released its latest research, “Contraceptives Marke

Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation

Nov, 2012  | Pages: 106
Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation Summary GBI Research, a leading business intelligence provider, has released

HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth

Nov, 2012  | Pages: 111
HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth Summary GBI Research, a leading business intelligence provider, has released its latest research, “HIV

Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

Nov, 2012  | Pages: 70
Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth Summary GBI Research, the leading business intelligence provider,

Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy

Nov, 2012  | Pages: 137
Women’s Health Therapeutics Market to 2018 - Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy Summary GBI Research, a leading business intelligence provider, has releas

1300 Smiles Limited (ONT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aug, 2012  | Pages: 19
1300 Smiles Limited (ONT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary 1300 Smiles Limited (Smiles) is a dental service company, provides dentistry services in Australia to private dentists. The company provides facilities s

22nd Century Group, Inc. (XXII) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aug, 2012  | Pages: 12
22nd Century Group, Inc. (XXII) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary 22nd Century Group, Inc. is a metals and mining company. The company is engaged in acquisition, exploration and development of mineral resource pro
Pages:   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 Next Page  1  of  150   
 
 
 

Browse Catalogue

 Retail Industry Market Research Reports
 

Related Industries

Healthcare Industry
... more industries
 

Market PRs


By: www.marketpressrelease.com
 

Subscription

Receive email alerts of new market research reports in your industry. Subscribe Today
 
 
 US Office
822 East Evelyn Avenue
# 722 , Sunnyvale
CA, USA
Zip: 94087
Tel: +1-408-5308892
info@marketsmonitor.com
 India Office
Plot No. 55, FIE
Patparganj Industrial Area
Delhi, India - 110092
Tel:-+91-11-42141242
       +91-9811336614
info@marketsmonitor.com

Please Fill the Information

Name:
Email: *
Phone:
Company: